person

Víctor L. L.

Country
Spain
Department
Ginecología

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 10 partner sites.

Specializations

Gynecologic Oncology

The investigator conducts studies on malignancies of the female reproductive system, including advanced ovarian and cervical cancers as well as hormone‑responsive breast disease.

  • Advanced ovarian cancer
  • High‑risk cervical cancer
  • Metastatic breast cancer
  • Endometrial carcinoma

Research is coordinated through the Department of Gynecology at Hospital Universitario y Politécnico La Fe in Valencia, Spain.

Hematologic Malignancies

Focused on clonal blood disorders, the investigator evaluates therapeutic strategies for acute and chronic myeloid diseases and lymphoid neoplasms.

  • Acute myeloid leukemia
  • Myelodysplastic syndrome
  • Diffuse large B‑cell lymphoma
  • Multiple myeloma

These efforts address both frontline and relapsed disease settings across adult and pediatric populations.

Autoimmune and Inflammatory Disorders

The clinical program includes systemic autoimmune conditions and chronic inflammatory bowel diseases, targeting immune modulation and disease remission.

  • Systemic lupus erythematosus
  • Ulcerative colitis
  • Crohn’s disease
  • Psoriatic arthritis
  • Generalized myasthenia gravis

Clinical investigations span moderate‑to‑severe disease activity and refractory patient cohorts.

Neurodegenerative and Neurological Diseases

Research in neuro‑medicine addresses progressive neurodegeneration and seizure disorders, emphasizing disease‑modifying approaches.

  • Alzheimer disease
  • Amyotrophic lateral sclerosis
  • Multiple sclerosis
  • Focal epilepsy

Study populations include early‑stage and advanced disease phenotypes.

Liver and Metabolic Syndromes

Investigations target acute‑on‑chronic liver failure and chronic hepatic conditions, integrating metabolic risk factors and viral hepatitis.

  • Acute‑on‑chronic liver failure
  • Chronic hepatitis B
  • Non‑alcoholic steatohepatitis
  • Liver cirrhosis

Therapeutic goals focus on organ preservation, transplant eligibility, and reduction of mortality.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.